MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, W.
Right arrow Articles by Pessah, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, W.
Right arrow Articles by Pessah, I. N.

Vol. 55, Issue 5, 821-831, May 1999

Site-Selective Modification of Hyperreactive Cysteines of Ryanodine Receptor Complex by Quinones

Wei Feng, Guohua Liu, Ruohong Xia, Jonathan J. Abramson, and Isaac N. Pessah

Department of Molecular Biosciences (W.F., G.L., R.X., I.N.P.), School of Veterinary Medicine, University of California, Davis, California; and Department of Physics (J.J.A.), Portland State University, Portland, Oregon

Quinones undergo redox cycling and/or arylation reactions with key biomolecules involved with cellular Ca2+ regulation. The present study utilizes nanomolar quantities of the fluorogenic maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin (CPM) to measure the reactivity of hyperreactive sulfhydryl moieties on sarcoplasmic reticulum (SR) membranes in the presence and absence of quinones by analyzing the kinetics of forming CPM-thioether adducts and localization of fluorescence by SDS-polyacrylamide gel electrophoresis. Doxorubicin, 1,4-naphthoquinone (NQ), and 1,4-benzoquinone (BQ) are found to selectively and dose-dependently interact with a class of hyperreactive sulfhydryl groups localized on ryanodine-sensitive Ca2+ channels [ryanodine receptor (RyR)], and its associated protein, triadin, of skeletal type channels. NQ and BQ are the most potent compounds tested for reducing the rate of CPM labeling of hyperreactive SR thiols (IC50 = 0.3 and 1.8 µM, respectively) localized on RyR and associated protein. The reduced forms of quinone, tert-butylhydroquinone, and 5-imino-daunorubicin do not alter significantly the pattern or kinetics of CPM labeling up to 100 µM, demonstrating that the quinone group is essential for modulating the state of hyperreactive SR thiols. Nanomolar NQ is shown to enhance the association of [3H]ryanodine for its high-affinity binding site and directly enhance channel-open probability in bilayer lipid membrane in a reversible manner. By contrast, micromolar NQ produces a time-dependent biphasic action on channel function, leading to irreversible channel inactivation. These results provide evidence that nanomolar quinone selectively and reversibly alters the redox state of hyperreactive sulfhydryls localized in the RyR/Ca2+ channel complex, resulting in enhanced channel activation. The Ca2+-dependent cytotoxicities observed with reactive quinones formed at the microsomal surface by oxidative metabolism may be related to their ability to selectively modify hyperreactive thiols regulating normal functioning of microsomal Ca2+ release channels.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. J. Phimister, J. Lango, E. H. Lee, M. A. Ernst-Russell, H. Takeshima, J. Ma, P. D. Allen, and I. N. Pessah
Conformation-dependent Stability of Junctophilin 1 (JP1) and Ryanodine Receptor Type 1 (RyR1) Channel Complex Is Mediated by Their Hyper-reactive Thiols
J. Biol. Chem., March 23, 2007; 282(12): 8667 - 8677.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li
Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1136 - H1144.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. K. Scott, C. Atsriku, P. Kaminker, J. Held, B. Gibson, M. A. Baldwin, and C. C. Benz
Vitamin K3 (Menadione)-Induced Oncosis Associated with Keratin 8 Phosphorylation and Histone H3 Arylation
Mol. Pharmacol., September 1, 2005; 68(3): 606 - 615.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. D. Fessenden, W. Feng, I. N. Pessah, and P. D. Allen
Mutational Analysis of Putative Calcium Binding Motifs within the Skeletal Ryanodine Receptor Isoform, RyR1
J. Biol. Chem., December 17, 2004; 279(51): 53028 - 53035.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. A. Voss, J. Lango, M. Ernst-Russell, D. Morin, and I. N. Pessah
Identification of Hyperreactive Cysteines within Ryanodine Receptor Type 1 by Mass Spectrometry
J. Biol. Chem., August 13, 2004; 279(33): 34514 - 34520.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G. Cherednichenko, A. V. Zima, W. Feng, S. Schaefer, L. A. Blatter, and I. N. Pessah
NADH Oxidase Activity of Rat Cardiac Sarcoplasmic Reticulum Regulates Calcium-Induced Calcium Release
Circ. Res., March 5, 2004; 94(4): 478 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. R. Bidasee, K. Nallani, H. R. Besch Jr., and U. D. Dincer
Streptozotocin-Induced Diabetes Increases Disulfide Bond Formation on Cardiac Ryanodine Receptor (RyR2)
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 989 - 998.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Tokarska-Schlattner, T. Wallimann, and U. Schlattner
Multiple Interference of Anthracyclines with Mitochondrial Creatine Kinases: Preferential Damage of the Cardiac Isoenzyme and Its Implications for Drug Cardiotoxicity
Mol. Pharmacol., March 1, 2002; 61(3): 516 - 523.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. L. Haak, L.-S. Song, T. F. Molinski, I. N. Pessah, H. Cheng, and J. T. Russell
Sparks and Puffs in Oligodendrocyte Progenitors: Cross Talk between Ryanodine Receptors and Inositol Trisphosphate Receptors
J. Neurosci., June 1, 2001; 21(11): 3860 - 3870.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
I. N. Pessah, C. Beltzner, S. W. Burchiel, G. Sridhar, T. Penning, and W. Feng
A Bioactive Metabolite of Benzo[a]pyrene, Benzo[a]pyrene-7,8-dione, Selectively Alters Microsomal Ca2+ Transport and Ryanodine Receptor Function
Mol. Pharmacol., March 1, 2001; 59(3): 506 - 513.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. R. Bidasee, A. Maxwell, W. F. Reynolds, V. Patel, and H. R. Besch Jr.
Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1074 - 1083.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. P. Moore, J.-Z. Zhang, and S. L. Hamilton
A Role for Cysteine 3635 of RYR1 in Redox Modulation and Calmodulin Binding
J. Biol. Chem., December 24, 1999; 274(52): 36831 - 36834.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Ito, Y. Hirata, H. Nakamura, and Y. Ohizumi
Xestoquinone, Isolated from Sea Sponge, Causes Ca2+ Release through Sulfhydryl Modification from Skeletal Muscle Sarcoplasmic Reticulum
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 976 - 981.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
W. Feng, G. Liu, P. D. Allen, and I. N. Pessah
Transmembrane Redox Sensor of Ryanodine Receptor Complex
J. Biol. Chem., November 10, 2000; 275(46): 35902 - 35907.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics